Canada’s Response on Monkeypox

August 14, 2024 | Ottawa, ON

The Government of Canada has taken action following the World Health Organization’s (WHO) declaration of a Public Health Emergency of International Concern (PHEIC) due to the rise in mpox cases across several African countries. The new strain, clade I mpox, is rapidly spreading from the Democratic Republic of the Congo (DRC). While no cases of this strain have been reported in Canada, the government is closely monitoring the situation.

Canada continues to manage an ongoing outbreak of clade II mpox, first detected in 2022, which has seen a recent increase in cases, especially in Toronto. Fortunately, clade II mpox has been deemed less severe than clade I. In response, Canada has ramped up wastewater surveillance, ensuring the ability to detect both strains of mpox across the country.

Vaccination efforts are ongoing, with the National Advisory Committee on Immunization (NACI) recommending a two-dose vaccine series for those at high risk. At this time, vaccines are not recommended for the general public, as the risk remains low.

Canada remains committed to global collaboration, providing millions in funding to the WHO’s Contingency Fund for Emergencies and working with Gavi, the Vaccine Alliance, to ensure equitable vaccine access globally.

As the situation evolves, the Government of Canada will continue to update the public and explore additional support avenues, working closely with international partners to mitigate the impact of this public health emergency.

Stay safe, stay informed, and follow all travel health advice if planning trips to regions experiencing mpox outbreaks.